Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Pulmonary Artery Hypertension
NCT02102672Phase 2Unknown
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trimetazidine in pulmonary arterial hypertension (PAH), sponsored by Pontificia Universidad Católica de Chile. Status: unknown.
02
Drugs
trimetazidine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02102672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102672.